HK1049122B - The use of mirtazapine for the treatment of sleep disorders - Google Patents

The use of mirtazapine for the treatment of sleep disorders Download PDF

Info

Publication number
HK1049122B
HK1049122B HK03101379.6A HK03101379A HK1049122B HK 1049122 B HK1049122 B HK 1049122B HK 03101379 A HK03101379 A HK 03101379A HK 1049122 B HK1049122 B HK 1049122B
Authority
HK
Hong Kong
Prior art keywords
mirtazapine
treatment
sleep
dose
sleep disorders
Prior art date
Application number
HK03101379.6A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1049122A1 (en
Inventor
Gerardus Stephanus Franciscus Ruigt
Frans Van Den Berg
Original Assignee
N. V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N. V. Organon filed Critical N. V. Organon
Publication of HK1049122A1 publication Critical patent/HK1049122A1/en
Publication of HK1049122B publication Critical patent/HK1049122B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK03101379.6A 2000-02-11 2001-02-06 The use of mirtazapine for the treatment of sleep disorders HK1049122B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00200499 2000-02-11
EP00200499.2 2000-02-11
PCT/EP2001/001221 WO2001058453A1 (en) 2000-02-11 2001-02-06 The use of mirtazapine for the treatment of sleep disorders

Publications (2)

Publication Number Publication Date
HK1049122A1 HK1049122A1 (en) 2003-05-02
HK1049122B true HK1049122B (en) 2006-04-21

Family

ID=8171013

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03101379.6A HK1049122B (en) 2000-02-11 2001-02-06 The use of mirtazapine for the treatment of sleep disorders

Country Status (25)

Country Link
US (1) US6933293B2 (cg-RX-API-DMAC7.html)
EP (4) EP2283840A1 (cg-RX-API-DMAC7.html)
JP (1) JP5039994B2 (cg-RX-API-DMAC7.html)
KR (1) KR20020069371A (cg-RX-API-DMAC7.html)
CN (2) CN101229170A (cg-RX-API-DMAC7.html)
AR (1) AR027394A1 (cg-RX-API-DMAC7.html)
AT (1) ATE317261T1 (cg-RX-API-DMAC7.html)
AU (1) AU780439B2 (cg-RX-API-DMAC7.html)
BR (1) BR0108261A (cg-RX-API-DMAC7.html)
CA (1) CA2396209C (cg-RX-API-DMAC7.html)
CO (1) CO5271706A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ302368B6 (cg-RX-API-DMAC7.html)
DE (1) DE60117122T2 (cg-RX-API-DMAC7.html)
DK (1) DK1257278T3 (cg-RX-API-DMAC7.html)
ES (1) ES2258071T3 (cg-RX-API-DMAC7.html)
HK (1) HK1049122B (cg-RX-API-DMAC7.html)
HU (1) HUP0204391A3 (cg-RX-API-DMAC7.html)
IL (2) IL150290A0 (cg-RX-API-DMAC7.html)
NO (1) NO328007B1 (cg-RX-API-DMAC7.html)
PE (1) PE20011080A1 (cg-RX-API-DMAC7.html)
PL (1) PL206073B1 (cg-RX-API-DMAC7.html)
RU (1) RU2270680C2 (cg-RX-API-DMAC7.html)
SK (1) SK287396B6 (cg-RX-API-DMAC7.html)
WO (1) WO2001058453A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200205238B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040152055A1 (en) * 2003-01-30 2004-08-05 Gliessner Michael J.G. Video based language learning system
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
WO2005051349A2 (en) * 2003-11-25 2005-06-09 Aurobindo Pharma Ltd. Pharmaceutical compositions of mirtazapine
GB0417558D0 (en) * 2004-08-06 2004-09-08 Merck Sharp & Dohme Novel combination therapy
AU2005292853C1 (en) * 2004-10-14 2010-08-05 Daikin Industries, Ltd. Atmosphere modifying method and spray agent and spray device used in the same
JP2006137748A (ja) * 2004-10-14 2006-06-01 Daikin Ind Ltd 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
JP2007284363A (ja) * 2006-04-13 2007-11-01 Daikin Ind Ltd 噴霧剤
WO2008125578A2 (en) 2007-04-11 2008-10-23 N.V. Organon A method for the preparation of mirtazapine
SI3261645T1 (sl) 2015-02-27 2021-08-31 Dechra Limited Stimulacija apetita, uravnavanje izgube mase in zdravljenje anoreksije pri psih in mačkah
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
JPH08502049A (ja) * 1992-10-07 1996-03-05 アクゾ ノーベル ナムローゼ フェンノートシャップ ラセミ体混合物からエナンチオマーを分離する方法
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
ATE289816T1 (de) 1997-11-14 2005-03-15 Akzo Nobel Nv Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen

Also Published As

Publication number Publication date
NO328007B1 (no) 2009-11-09
EP1257278A1 (en) 2002-11-20
US6933293B2 (en) 2005-08-23
NO20023803L (no) 2002-10-09
CZ302368B6 (cs) 2011-04-13
ATE317261T1 (de) 2006-02-15
IL150290A0 (en) 2002-12-01
RU2002124141A (ru) 2004-03-10
DE60117122D1 (de) 2006-04-20
PL356721A1 (en) 2004-06-28
CN101229170A (zh) 2008-07-30
DK1257278T3 (da) 2006-06-12
CZ20022330A3 (cs) 2002-11-13
HK1049122A1 (en) 2003-05-02
ES2258071T3 (es) 2006-08-16
HUP0204391A3 (en) 2005-03-29
JP5039994B2 (ja) 2012-10-03
AU780439B2 (en) 2005-03-24
JP2003522147A (ja) 2003-07-22
EP1257278B1 (en) 2006-02-08
BR0108261A (pt) 2003-03-05
ZA200205238B (en) 2003-09-29
WO2001058453A1 (en) 2001-08-16
IL150290A (en) 2010-12-30
CO5271706A1 (es) 2003-04-30
EP1656937A1 (en) 2006-05-17
SK287396B6 (sk) 2010-08-09
CN1395487A (zh) 2003-02-05
PL206073B1 (pl) 2010-06-30
AR027394A1 (es) 2003-03-26
DE60117122T2 (de) 2006-07-27
NO20023803D0 (no) 2002-08-09
RU2270680C2 (ru) 2006-02-27
HUP0204391A2 (en) 2003-05-28
EP2283840A1 (en) 2011-02-16
CA2396209A1 (en) 2001-08-16
CA2396209C (en) 2009-09-01
EP1658850A1 (en) 2006-05-24
SK11442002A3 (sk) 2003-02-04
US20030022888A1 (en) 2003-01-30
KR20020069371A (ko) 2002-08-30
PE20011080A1 (es) 2001-10-18
AU3024701A (en) 2001-08-20

Similar Documents

Publication Publication Date Title
GARFINKEL et al. Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children
NZ196048A (en) Anti-depressant compositions with reduced induction of drowsiness-benzodiazepine tranquilliser/m-(chloro or fluoro)-t-butylaminopropiophenone
EP1257278B1 (en) The use of mirtazapine for the treatment of sleep disorders
US20080182890A1 (en) Methods of using low-dose doxepin for the improvement of sleep
RU2268725C2 (ru) Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств
EP0282818B1 (en) The use of gepirone for preparing a pharmaceutical composition for the treatment of atypical depression
JPH0920666A (ja) 成熟遅延および類似疾患の治療用医薬組成物
Mendelson Pharmacotherapy of insomnia
HK1087356A (en) The use of mirtazapine for the treatment of sleep disorders
HK1087359A (en) The use of mirtazapine for the treatment of sleep disorders
HK1150978A (en) The use of mirtazapine for the treatment of sleep disorders
Kerr et al. The effects of acute and repeated doses of moclobemide on psychomotor performance and cognitive function in healthy elderly volunteers
MXPA02006710A (en) The use of mirtazapine for the treatment of sleep disorders
Middleton Temazepam (Euhypnos®) and chlormethiazole: a comparative study in geriatric patients
TWI297607B (en) The use of mirtazapine for the treatment of sleep disorders and pharmaceutical composition comprising mirtazapine
Laddha et al. Drugs impairment on driving performance: an overview
Pollack et al. Variables in the clinical evaluation of a hypnotic drug with a clinical evaluation of glutethimide
Goldstein et al. Picenadol in a large multicenter dental pain study
Armstrong Prevention of traveller's diarrhea with doxycycline
MIN PRESCRIBE

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120206